Addus HomeCare (NASDAQ:ADUS) EVP Cliff Donald Blessing Sells 350 Shares of Stock

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Cliff Donald Blessing sold 350 shares of the company’s stock in a transaction that occurred on Tuesday, February 24th. The stock was sold at an average price of $107.14, for a total value of $37,499.00. Following the completion of the sale, the executive vice president owned 12,538 shares in the company, valued at approximately $1,343,321.32. This represents a 2.72% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Cliff Donald Blessing also recently made the following trade(s):

• On Wednesday, February 25th, Cliff Donald Blessing sold 177 shares of Addus HomeCare stock. The stock was sold at an average price of $105.36, for a total value of $18,648.72.

Addus HomeCare Price Performance

Addus HomeCare stock traded down $0.51 during trading hours on Friday, hitting $103.52. The stock had a trading volume of 14,471 shares, compared to its average volume of 233,037. Addus HomeCare Corporation has a 1-year low of $88.96 and a 1-year high of $124.43. The stock has a market capitalization of $1.92 billion, a price-to-earnings ratio of 19.85, a PEG ratio of 1.49 and a beta of 0.91. The stock’s fifty day moving average is $109.41 and its two-hundred day moving average is $113.01. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.80 and a quick ratio of 1.66.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on ADUS. Truist Financial set a $135.00 price target on shares of Addus HomeCare and gave the company a “buy” rating in a report on Wednesday, January 7th. BMO Capital Markets initiated coverage on Addus HomeCare in a report on Thursday, November 13th. They set a “market perform” rating and a $120.00 target price on the stock. Weiss Ratings reissued a “hold (c+)” rating on shares of Addus HomeCare in a report on Wednesday, January 21st. Royal Bank Of Canada restated an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a research report on Wednesday. Finally, Stephens dropped their price objective on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a research report on Wednesday. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $134.33.

Institutional Trading of Addus HomeCare

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Global Retirement Partners LLC increased its stake in shares of Addus HomeCare by 395.7% during the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock valued at $25,000 after acquiring an additional 186 shares during the last quarter. Larson Financial Group LLC grew its holdings in Addus HomeCare by 133.3% in the third quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after purchasing an additional 136 shares during the period. Acumen Wealth Advisors LLC acquired a new position in Addus HomeCare during the fourth quarter worth approximately $29,000. Private Trust Co. NA increased its position in Addus HomeCare by 65.5% during the fourth quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after purchasing an additional 112 shares during the last quarter. Finally, Arax Advisory Partners raised its stake in Addus HomeCare by 95.8% during the fourth quarter. Arax Advisory Partners now owns 280 shares of the company’s stock worth $30,000 after purchasing an additional 137 shares during the period. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare News Roundup

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Stephens retained an “Overweight” rating on ADUS and set a $135 price target (trimmed from $140), keeping a constructive analyst opinion that supports medium-term upside. Read More.
• Positive Sentiment: Large institutional investors increased positions in recent quarters (Capital Research, Vanguard, Wasatch, State Street and others), signaling continued institutional confidence and buying power underneath the stock. Read More.
• Neutral Sentiment: Short-interest reporting is inconsistent across feeds (some entries show 0 shares, others show a material rise), creating data noise — investors should confirm with official FINRA/exchange data before sizing positions. Read More.
• Negative Sentiment: Insiders sold multiple tranches of stock on Feb. 24–25: CEO R. Dirk Allison sold several thousand shares (~7,300 across filings) and numerous EVPs also liquidated positions — concentrated insider selling often weighs on sentiment and can pressure the share price. Read More.
• Negative Sentiment: Reported short interest increased materially in February to roughly 1.15M shares (~6.5% of float, ~4.6 days to cover in mid-February) — a larger short book can amplify downside on negative headlines and increase volatility. Read More.
• Negative Sentiment: Media picked up a “pessimistic forecast” narrative tied to Stephens’ shorter-term expectations after the PT cut, which can reinforce selling pressure despite the retained Overweight rating. Read More.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.